Core Scientific, Inc. Common Stock Capital Reinvestment Ratio
Core Scientific, Inc. Common Stock capital reinvestment ratio. Core Scientific, Inc. Common Stock (CORZ) has a Capital Reinvestment Ratio of 1.56x as of March 2026, meaning it reinvests 2% of its operating cash flow ($249.88 Million) in capital expenditures ($389.23 Million). See Core Scientific, Inc. Common Stock free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Core Scientific, Inc. Common Stock (2022–2025)
Capital reinvestment ratio of Core Scientific, Inc. Common Stock from 2022 to 2025. This chart tracks Core Scientific, Inc. Common Stock's Capital Reinvestment Ratio across 4 annual periods. See Core Scientific, Inc. Common Stock (CORZ) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Core Scientific, Inc. Common Stock Capital Reinvestment Ratio by Year (2022–2025)
Core Scientific, Inc. Common Stock capital reinvestment ratio by year from 2022 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Core Scientific, Inc. Common Stock.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.62x | $278.25 Million | $729.00 Million | ▲ +18.3% |
| 2024 | 2.21x | $42.90 Million | $94.96 Million | ▲ +791.9% |
| 2023 | 0.25x | $65.11 Million | $16.16 Million | ▼ -91.5% |
| 2022 | 2.93x | $205.19 Million | $601.66 Million | — |